TP53 and myeloid neoplasm: Although there is a wealth of published literature attesting to the adverse prognostic effect of −7/7q8, 9 and del(17p),10, 11, 12, 13, 14, 15, 16 the independent impact of del(5q) within TP53‐mutated myeloid neoplasms outside the context of MDS with iso‐5q is poorly understood.